Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06597968 · ClinicalTrials.gov registry record
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
A clinical trial of Lung Nodule, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- 45,991
- Enrollment target
- 1
- Study location
NCT06597968: Recruiting study of Lung Nodule, sponsored by University Hospitals Cleveland Medical Center.
NCT06597968 is a study of Lung Nodule that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 45,991 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06597968, a study of Lung Nodule, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- 45,991 participants
- Enrollment target
- 1
- Study location
Study Summary
chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or not. The image will then be sent to a radiologist to determine if there is agreement or disagreement with the AI tool.
Conditions Studied
Interventions
- DEVICE AI Based CAD Software (qXR-Ln)
Study Locations (1)
Ohio
- University Hospitals - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45,991 participants |
| Start Date | 2025-06-24 |
| Est. Completion | 2026-04-30 |
What NCT06597968 shows while recruiting
NCT06597968 is an observational study that tracks outcomes without assigning an intervention. Its 45,991 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Lung Nodule appearing as the primary indexed condition, and to 1 intervention - of which AI Based CAD Software (qXR-Ln) is the first listed.
NCT06597968 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06597968 about?
NCT06597968 is a clinical study titled "Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool". chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or not. The image will ...
What is the current status of trial NCT06597968?
This trial is currently recruiting. The enrollment target is 45,991 participants. The study started on 2025-06-24. Estimated completion is 2026-04-30.
What conditions does trial NCT06597968 study?
This clinical trial studies the following conditions: Lung Nodule.
What interventions are being tested in trial NCT06597968?
The interventions under investigation include: AI Based CAD Software (qXR-Ln) (DEVICE).
Who is sponsoring clinical trial NCT06597968?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06597968 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- NCT06655974 · 48,000 participants · NA
Predictive Modeling for Social Needs in Emergency Department Settings
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI